Annual Report

Overview

The report highlights ALK's 2012 revenue of DKK 2,345 million and continued development of allergy immunotherapy products. It describes CSR across allergy access, environment, ethical conduct and employees, including ISO 14001 certification in Denmark and environmental data from production sites. The company reports 1,855 year-end employees and two women among nine directors. It also reports a 13% CO2 reduction against 2008, nearing its 15% 2014 objective.

Document

Report type: Annual Report
Class: Financial
Scope: Full report
Fiscal year: 2012
Period: 1 January 2012 – 31 December 2012
Publication date: 5 February 2013
Language: English
Pages
File size

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services